Clinics of Oncology
About Us
Author Guidelines
Contact
Editor in Chief
Editorial Board
Home
Peer Review Process
Submit Manuscript
Terms & Conditions
Volumes
Gemcitabine –Vinorelbine – Bevacizumab, for Bone Metastasesfrom Breast Cancer
Apr 5, 2024
—
by
in
Volume 1
Opinion Article
←
Previous:
Maintenance Trastuzumabplus Letrozoleafter Complete Responseto Trastuzumab-Emtansine in A Patient with HER2-Positive, Hormone Receptor Positive Metastatic Breast Cancer
Next:
Role of Bisphosphonate (Bps) in Breast Cancer: An Update
→
error:
Content is protected !!